Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Cancer, Duct Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05641896
What this trial is testing

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersCholangiocarcinomaGastric Cancer+3 more
SOFIE 109
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Looking for participantsNCT05688215
What this trial is testing

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center 56
Early research (Phase 1)Looking for participantsNCT05013216
What this trial is testing

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Who this might be right for
High Risk CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 37
Not applicableNo Longer AvailableNCT07399015
What this trial is testing

Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Unresectable Pancreatic Ductal AdenocarcinomaMetastatic PDAC
Endevica Bio
Early research (Phase 1)Ended earlyNCT06364696
What this trial is testing

Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

Who this might be right for
Solid Tumor
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)UnknownNCT04692740
What this trial is testing

Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Michele Reni 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04888312
What this trial is testing

Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Alligator Bioscience AB 94
Not applicableEnrolling By InvitationNCT06157671
What this trial is testing

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Intraepithelial Neoplasia
Adenocyte, LLC 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Large-scale testing (Phase 3)Looking for participantsNCT07155525
What this trial is testing

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

Who this might be right for
Pancreatic CancerPeriampullary CancerDuodenal Cancer+4 more
Minia University 194
Large-scale testing (Phase 3)Study completedNCT00425360
What this trial is testing

Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Liverpool University Hospital 1,110
Not applicableLooking for participantsNCT07500259
What this trial is testing

Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

Who this might be right for
Colorectal CancerPDAC - Pancreatic Ductal Adenocarcinoma
Luxembourg Institute of Health 188
Testing effectiveness (Phase 2)Study completedNCT01658943
What this trial is testing

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more
National Cancer Institute (NCI) 137
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07028424
What this trial is testing

PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group 206
Testing effectiveness (Phase 2)Looking for participantsNCT07223047
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+1 more
Bristol-Myers Squibb 252
Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing

PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31
Very early researchLooking for participantsNCT07089940
What this trial is testing

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more
OHSU Knight Cancer Institute 12
Not applicableWithdrawnNCT01911416
What this trial is testing

A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University of Utah
Testing effectiveness (Phase 2)Looking for participantsNCT07769502
What this trial is testing

Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers

Who this might be right for
Pancreatobiliary CancersPancreatic Ductal Adenocarcinoma
AbbVie 168
Next Page